An Update on the Role of Interim Restaging FDG-PET in Patients With Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma

被引：17

作者：

Moskowitz, Craig H. ^{[1
]}

Zelenetz, Andrew ^{[1
]}

Schoder, Heiko ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2010年 / 8卷 / 03期

关键词：

Diffuse large B-cell lymphoma; Hodgkin lymphoma; stem cell transplantation; interim FDG-PET; POSITRON-EMISSION-TOMOGRAPHY; BONE-MARROW-TRANSPLANTATION; HIGH-DOSE CHEMOTHERAPY; AGGRESSIVE LYMPHOMA; PROGNOSTIC VALUE; RESPONSE ASSESSMENT; PROGRESSION-FREE; CYCLES; DISEASE; RITUXIMAB;

D O I：

10.6004/jnccn.2010.0023

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A significant amount of literature is available on treatment monitoring and response assessment in lymphoma using FDG-PET, yet confusion exists concerning the potential and limitations of FDG-PET for determining the presence of residual disease during chemotherapy (interim FDG-PET) This article reviews the role of interim FDG-PET in 3 important scenarios untreated diffuse large B-cell lymphoma, untreated Hodgkin lymphoma, and relapsed or refractory aggressive lymphoma in transplant-eligible patients, and provides recommendations on the use of this imaging modality in these settings (JNCCN 2010,8 347-352)

引用

页码：347 / 352

页数：6

共 34 条

[1] Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphoma [J].

Avigdor, A. ;

Bulvik, S. ;

Levi, I. ;

Dann, E. J. ;

Shemtov, N. ;

Perez-Avraham, G. ;

Shimoni, A. ;

Nagler, A. ;

Ben-Bassat, I. ;

Polliack, A. .

ANNALS OF ONCOLOGY, 2010, 21 (01) :126-132

[2] Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation [J].

Becherer, A ;

Mitterbauer, M ;

Jaeger, U ;

Kalhs, P ;

Greinix, HT ;

Karanikas, G ;

Pötzi, C ;

Raderer, M ;

Dudczak, R ;

Kletter, K .

LEUKEMIA, 2002, 16 (02) :260-267

[3]

Cashen A, 2008, BLOOD, V112, P144

[4] Revised response criteria for malignant lymphoma [J].

Cheson, Bruce D. ;

Pfistner, Beate ;

Juweid, Malik E. ;

Gascoyne, Randy D. ;

Specht, Lena ;

Horning, Sandra J. ;

Coiffier, Bertrand ;

Fisher, Richard I. ;

Hagenbeek, Anton ;

Zucca, Emanuele ;

Rosen, Steven T. ;

Stroobants, Sigrid ;

Lister, T. Andrew ;

Hoppe, Richard T. ;

Dreyling, Martin ;

Tobinai, Kensei ;

Vose, Julie M. ;

Connors, Joseph M. ;

Federico, Massimo ;

Diehl, Volker .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :579-586

[5] Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: Report of an intergroup trial [J].

Duggan, DB ;

Petroni, GR ;

Johnson, JL ;

Glick, JH ;

Fisher, RI ;

Connors, JM ;

Canellos, GP ;

Peterson, BA .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (04) :607-614

[6] Value of F-18 fluorodeoxyglucose positron emission tomography for predicting the clinical outcome of patients with aggressive lymphoma prior to and after autologous stem-cell transplantation [J].

Filmont, JE ;

Czernin, J ;

Yap, C ;

Silverman, DHS ;

Quon, A ;

Phelps, ME ;

Emmanouilides, C .

CHEST, 2003, 124 (02) :608-613

[7] Early interim 2-[18F]Fluoro-2-Deoxy-D-Glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma:: A report from a joint Italian-Danish study [J].

Gallamini, Andrea ;

Hutchings, Martin ;

Rigacci, Luigi ;

Specht, Lena ;

Merli, Francesco ;

Hansen, Mads ;

Patti, Caterina ;

Loft, Annika ;

Di Raimondo, Francesco ;

D'Amore, Francesco ;

Biggi, Alberto ;

Vitolo, Umberto ;

Stelitano, Caterina ;

Sancetta, Rosario ;

Trentin, Livio ;

Luminari, Stefano ;

Iannitto, Emilio ;

Viviani, Simonetta ;

Pierri, Ivana ;

Levis, Alessandro .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (24) :3746-3752

[8]

Gallamini A, 2006, HAEMATOLOGICA, V91, P475

[9] High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma [J].

Gianni, AM ;

Bregni, M ;

Siena, S ;

Brambilla, C ;

DiNicola, M ;

Lombardi, F ;

Gandola, L ;

Tarella, C ;

Pileri, A ;

Ravagnani, F ;

Valagussa, P ;

Bonadonna, G ;

Stern, AC ;

Magni, M ;

Caracciolo, D .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (18) :1290-1297

[10] High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non-Hodgkin Lymphoma (NHL) in adults [J].

Greb, A. ;

Bohlius, J. ;

Schiefer, D. ;

Schwarzer, G. ;

Schulz, H. ;

Engert, A. .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (01)

← 1 2 3 4 →